Avidity Partners Management’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-1,482,200
Closed -$91.7M 116
2022
Q3
$91.7M Sell
1,482,200
-374,700
-20% -$26.2M 1.87% 20
2022
Q2
$148M Buy
1,856,900
+725,500
+64% +$68.7M 3.4% 10
2022
Q1
$119M Buy
1,131,400
+119,400
+12% +$11.6M 2.48% 14
2021
Q4
$109M Buy
1,012,000
+186,000
+23% +$20.3M 2.31% 14
2021
Q3
$90.5M Buy
826,000
+258,000
+45% +$26.8M 2% 13
2021
Q2
$53.2M Sell
568,000
-13,000
-2% -$1.2M 1.44% 26
2021
Q1
$53.5M Sell
581,000
-588,300
-50% -$49.6M 1.48% 23
2020
Q4
$85.5M Buy
1,169,300
+239,100
+26% +$17.8M 2.78% 9
2020
Q3
$72.3M Buy
930,200
+394,000
+73% +$27.1M 3.35% 8
2020
Q2
$29.8M Buy
536,200
+203,200
+61% +$8.69M 1.91% 18
2020
Q1
$9.86M Buy
333,000
+183,000
+122% +$6.19M 1.36% 29
2019
Q4
$5.43M Buy
+150,000
New +$4.6M 3.42% 12

Other funds holding HZNP